CLINICAL TRIAL / NCT06511401

Informing Pain Treatment Using Pharmacogenomic Analysis

  • Interventional
  • Recruiting
  • NCT06511401

C-PAIN: Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment

This is a randomized, prospective study to evaluate the effects of preemptive pharmacogenomic (PGx) testing on opioid dosing decisions/selections and pain score in cancer patients.